Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Long-Term Debt Repayments (2019 - 2022)

Bioadaptives' Long-Term Debt Repayments history spans 4 years, with the latest figure at $9282.0 for Q2 2022.

  • For Q2 2022, Long-Term Debt Repayments fell 7.18% year-over-year to $9282.0; the TTM value through Mar 2023 reached $9282.0, down 74.21%, while the annual FY2022 figure was $25272.0, 26.36% up from the prior year.
  • Long-Term Debt Repayments for Q2 2022 was $9282.0 at Bioadaptives, down from $15990.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $15990.0 in Q1 2022 and bottomed at -$8150.0 in Q2 2020.
  • The 4-year median for Long-Term Debt Repayments is $9282.0 (2022), against an average of $7352.4.
  • The largest annual shift saw Long-Term Debt Repayments skyrocketed 222.7% in 2021 before it fell 7.18% in 2022.
  • A 4-year view of Long-Term Debt Repayments shows it stood at $6195.0 in 2019, then plummeted by 231.56% to -$8150.0 in 2020, then surged by 222.7% to $10000.0 in 2021, then fell by 7.18% to $9282.0 in 2022.
  • Per Business Quant, the three most recent readings for BDPT's Long-Term Debt Repayments are $9282.0 (Q2 2022), $15990.0 (Q1 2022), and $10000.0 (Q3 2021).